NCLEX Questions With Rationales / Pharmacology / Drug Classes & Mechanisms
NCLEX Questions With Rationales

Antidepressants NCLEX Questions With Rationales

Pharmacology · Drug Classes & Mechanisms·Updated 2026-11-19

What it is

Antidepressants are medications that modify neurotransmitter activity to treat depression and other psychiatric conditions. They affect neurotransmitters such as serotonin, norepinephrine, and dopamine. Different classes have different adverse effects, interactions, and safety precautions, making medication assessment and client education essential.

What the NCLEX focuses on

  • Selective serotonin reuptake inhibitors (SSRIs), including fluoxetine, sertraline, citalopram, escitalopram, and paroxetine, increase serotonin availability and are commonly prescribed as first-line antidepressants.
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs), including venlafaxine and duloxetine, increase serotonin and norepinephrine activity.
  • Tricyclic antidepressants (TCAs), including amitriptyline and imipramine, affect serotonin and norepinephrine but commonly produce anticholinergic effects and can cause life-threatening cardiac toxicity in overdose.
  • Monoamine oxidase inhibitors (MAOIs), including phenelzine, tranylcypromine, and isocarboxazid, prevent neurotransmitter breakdown and require dietary and medication restrictions.
  • Bupropion inhibits norepinephrine and dopamine reuptake and generally causes fewer sexual adverse effects than SSRIs, but it increases seizure risk in susceptible clients.
  • Mirtazapine increases noradrenergic and serotonergic neurotransmission and commonly causes sedation, increased appetite, and weight gain.
  • Antidepressants generally require several weeks for meaningful therapeutic improvement, although sleep, appetite, or concentration may improve earlier.
  • The FDA boxed warning identifies increased suicidal thoughts and behaviors in children, adolescents, and young adults taking antidepressants, particularly during early treatment and dose changes.
  • Serotonin syndrome is a potentially life-threatening reaction characterized by agitation, confusion, hyperthermia, sweating, diarrhea, tremor, muscle rigidity, hyperreflexia, and clonus. It usually begins within hours of adding or increasing a serotonergic drug.

Priority nursing actions

  • Assess depression severity, suicidal ideation, previous attempts, medication history, bipolar symptoms, and current use of prescription drugs, over-the-counter products, and herbal supplements.
  • Monitor closely for worsening depression, agitation, unusual behavior, and suicidal thoughts when starting treatment or changing the dose. Assess immediately when suicidal thoughts emerge.
  • Recognize serotonin syndrome when serotonergic medications are combined, particularly SSRIs or SNRIs with MAOIs, other serotonergic drugs, or St. John's wort. Hold suspected causative medications and arrange emergency evaluation.
  • Monitor for SSRI adverse effects such as nausea, diarrhea, insomnia, headache, sweating, and sexual dysfunction. Assess for clinically significant bleeding or hyponatremia when risk factors are present.
  • Monitor clients taking TCAs for anticholinergic effects, including dry mouth, blurred vision, constipation, urinary retention, and orthostatic hypotension. Suspected overdose requires emergency cardiac assessment.
  • For clients taking MAOIs, monitor blood pressure and assess severe headache, palpitations, chest pain, and hypertension that may indicate a hypertensive crisis.

Numbers to know

ValueNumberWhy it matters
Usual therapeutic onset4 to 8 weeksFull antidepressant benefit may take several weeks.
FDA increased suicidality risk groupYounger than 25 yearsRequires close monitoring during treatment initiation and dose changes.
MAOI washout before starting another antidepressantAt least 14 daysReduces the risk of serious drug interactions.
Fluoxetine washout before starting an MAOIAt least 5 weeksFluoxetine and its active metabolite have prolonged elimination.
Usual discontinuation taperSeveral weeks or monthsGradual dose reduction helps reduce discontinuation symptoms.

Common exam traps

  • Choosing to discontinue an SSRI immediately when mood improves: wrong because abrupt discontinuation can cause dizziness, nausea, insomnia, irritability, and sensory disturbances.
  • Choosing to ignore increased energy when depression remains severe: wrong because improved energy before mood recovery may increase the ability to act on suicidal thoughts.
  • Choosing an SSRI together with an MAOI without an appropriate washout: wrong because the combination can cause life-threatening serotonin syndrome.
  • Choosing aged cheese and cured meats for a client taking phenelzine: wrong because tyramine can precipitate a hypertensive crisis.
  • Choosing a TCA for a client with a high risk of intentional overdose without considering toxicity: wrong because TCA overdose can cause seizures, severe hypotension, and fatal cardiac dysrhythmias.

What to teach

  • Take antidepressants exactly as prescribed and do not stop, increase, or decrease doses without consulting the prescriber.
  • Report new or worsening suicidal thoughts, severe agitation, unusual behavioral changes, or increased impulsivity immediately. Family members should monitor for these changes, particularly early in treatment.
  • Avoid combining serotonergic medications or herbal products such as St. John's wort without provider approval. Report all medications and supplements before starting treatment.
  • Clients taking MAOIs should avoid high-tyramine foods, including aged cheeses, cured or fermented meats, fermented soy products, and certain aged or fermented beverages. Seek emergency care for a sudden severe headache, chest pain, or palpitations.
  • Teach that MAOIs require a medication washout when switching antidepressants. The exact interval depends on the drugs involved, and fluoxetine requires a longer interval because of its long half-life.
  • Explain that antidepressant discontinuation symptoms can include flu-like symptoms, dizziness, nausea, insomnia, anxiety, and electric shock-like sensations. Gradual tapering under prescriber supervision reduces this risk.

2 NCLEX questions with rationales on this topic

From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.

Question 1 · QID 6AF06B3C

A client taking sertraline for 8 months wants to stop the medication because they feel well. Which instruction is most appropriate?

Select the best answer.

  1. A. "Work with your prescriber on a gradual taper, not a sudden stop."
  2. B. "You have felt well for months, so stop it now and call if symptoms return."
  3. C. "Cut your dose in half tomorrow, stay there a week, then stop."
  4. D. "Stopping affects mood but does not cause physical withdrawal symptoms."
Show the correct answer and rationale

Correct answer:

  • A. "Work with your prescriber on a gradual taper, not a sudden stop."

Rationale

Overview

  • Definition: SSRI discontinuation syndrome follows abrupt cessation or rapid dose reduction after sustained treatment.
  • Signs and symptoms: Dizziness, nausea, flu-like symptoms, insomnia, electric-shock sensations, and irritability develop within days.
  • How to stop: An individualized prescriber-guided taper usually extends over weeks; some clients require longer.

Nursing key points

  • Refer the request to the prescriber before dose changes.
  • Review time since remission; first-episode treatment continues at least 6 to 12 months after remission.
  • Follow the individualized taper.
  • Report discontinuation symptoms and recurrent depression promptly.

Answer analysis

Instruction to the clientRationale
"Work with your prescriber on a gradual taper, not a sudden stop."Correct. Prescriber-guided tapering reduces discontinuation symptoms.
"You have felt well for months, so stop it now and call if symptoms return."Not correct. Abrupt cessation risks withdrawal and relapse.
"Cut your dose in half tomorrow, stay there a week, then stop."Not correct. This fixed reduction ignores individual tolerance.
"Stopping affects mood but does not cause physical withdrawal symptoms."Not correct. Sustained use does not prevent physical discontinuation symptoms.
Question 2 · QID D4DEC538

The nurse assesses a client taking two serotonergic medications together. For each finding, indicate whether it is consistent with serotonin syndrome or is not consistent with it.

Consistent with serotonin syndromeNot consistent
Profuse sweating and tremor
Agitation and confusion with a temperature of 39.2 C (102.6 F)
Slow, shallow respirations with pinpoint pupils
Rapid onset within hours of adding the second serotonergic drug
Muscle rigidity and overactive (hyperactive) reflexes
Show the correct answer and rationale

Correct answers:

  • Profuse sweating and tremor: Consistent with serotonin syndrome
  • Agitation and confusion with a temperature of 39.2 C (102.6 F): Consistent with serotonin syndrome
  • Slow, shallow respirations with pinpoint pupils: Not consistent
  • Rapid onset within hours of adding the second serotonergic drug: Consistent with serotonin syndrome
  • Muscle rigidity and overactive (hyperactive) reflexes: Consistent with serotonin syndrome

Rationale

Overview

  • Definition: Serotonin syndrome results from excessive serotonergic activity, usually beginning within hours of increased exposure.
  • Triad: Mental-status changes, autonomic hyperactivity, and neuromuscular excitation characterize toxicity. Clonus and hyperreflexia are central assessment findings.
  • What it is not: Respiratory depression with pinpoint pupils is not the characteristic pattern.

Nursing key points

  • Review serotonergic medications, supplements, and recent dose changes.
  • Assess clonus, reflexes, mental status, and temperature.
  • Apply Hunter criteria to the complete examination; clonus, agitation, diaphoresis, hyperreflexia, and fever guide assessment.
  • Withhold suspected agents and obtain urgent medical review.

Answer analysis

Assessment findingSerotonin syndrome?Why
Profuse sweating and tremorConsistent with serotonin syndrome.These reflect autonomic and neuromuscular excitation.
Agitation and confusion with a temperature of 39.2 C (102.6 F)Consistent with serotonin syndrome.Altered mental status and hyperthermia fit the syndrome.
Slow, shallow respirations with pinpoint pupilsNot consistent.This pattern indicates opioid toxicity and requires immediate respiratory support.
Rapid onset within hours of adding the second serotonergic drugConsistent with serotonin syndrome.Toxicity develops rapidly after increased serotonergic exposure.
Muscle rigidity and overactive (hyperactive) reflexesConsistent with serotonin syndrome.Increased tone and hyperreflexia indicate neuromuscular excitation; assess clonus.
Want more questions on this topic?

The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.

Create Account →

More topics in Pharmacology

Proton Pump Inhibitors and Antacids NCLEX Questions With RationalesReviews acid-suppressing medications, administration, adverse effects, drug interactions, and nursing priorities for gastrointestinal bleeding.Calcium Channel Blockers NCLEX Questions With RationalesReviews calcium channel blocker classes, cardiovascular uses, adverse effects, nursing assessments, medication safety, and client teaching.Statins NCLEX Questions With RationalesReviews statin medications, LDL reduction, adverse effects, drug interactions, laboratory monitoring, and client education.

Sources

Practice the NCLEX questions on this topic

3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.

Create Account →